Status:
NOT_YET_RECRUITING
Celiac plExus Block to Reduce OpioID Consumption Following Hepato-pancreato-biliary Mini-invasive Surgery
Lead Sponsor:
Sixth Affiliated Hospital, Sun Yat-sen University
Conditions:
Pancreatic Ductal Adenocarcinoma
Liver, Cancer of, Primary Resectable
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to assess the efficacy of intraoperative celiac plexus block (CPB) to reduce opioid consumption following laparoscopic hepato-pancreato-biliary surgery
Detailed Description
A bilateral CPB is convenient and safe to perform under the direct laparoscopic vision of the surgeons during surgery; however, perspective data are warranted. The investigators hypothesize that a bil...
Eligibility Criteria
Inclusion
- Over age 18
- Undergoing laparoscopic hepato-pancreato-biliary surgery
Exclusion
- Patient refuse
- Relatively contraindications: severe heart, liver, or kidney dysfunction, coagulation dysfunction, and local anesthetic allergy history
- Intervention unlikely to be effective: drug abuse history, receiving other types of nerve block treatment
- Unlikely to complete the follow-up: alcoholism, planned to replace WeChat and phone within three months; the expected life span less than three months
- Unable to cooperate with the questionnaire and use the patient-controlled analgesia pump
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06214533
Start Date
March 1 2024
End Date
December 31 2025
Last Update
January 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.